• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma

    2010-06-29 10:13:48HaiYingYuDaiRongXiangHaiJunHuangJunLiandJiFangSheng

    Hai-Ying Yu, Dai-Rong Xiang, Hai-Jun Huang, Jun Li and Ji-Fang Sheng

    Hangzhou, China

    Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma

    Hai-Ying Yu, Dai-Rong Xiang, Hai-Jun Huang, Jun Li and Ji-Fang Sheng

    Hangzhou, China

    BACKGROUND:Augmenter of liver regeneration (ALR) is an important polypeptide in the process of liver regeneration. This study aimed to determine the expression level of ALR in different liver diseases and its significance.

    METHODS:We prepared murine polyclonal antibody against ALR protein from Balb/C mice and purified the IgG fraction, which specifically combined to ALR protein as shown by Western blotting. Serum ALR levels in patients with hepatocellular carcinoma (HCC), hepatic failure (HF), chronic hepatitis B, and healthy persons were compared by ELISA. ALR mRNA expression levels in liver tissues in some of these patients were also compared by real-time RT-PCR. Immunohistochemical analysis was carried out on HF and HCC liver tissues.

    RESULTS:Different serum ALR levels foreshowed completely different prognoses in 18 HF patients. Higher ALR levels were noted in 6 improved patients (1613.5±369.6 pmol/ml) than in 12 deteriorating patients (462.3±235.8 pmol/ml). Similar levels were found in 20 HCC patients (917.9±332. 7 pmol/ml), 24 chronic hepatitis B patients (969.2±332.5 pmol/ml) and 10 healthy persons (806.9±240.8 pmol/ml). ALR mRNA levels in HCC liver tissues [10E6.24 (1.74×106) copies/μl] were much higher than in those of HF patients receiving orthotopic liver transplantation [10E3.45 (2.82×103)copies/μl] or in healthy liver tissues [10E4.31 (2.04×104) copies/μl]. In immunohistochemical analysis, positive immunostaining in HCC liver tissue was more intense than that in HF liver tissue.

    CONCLUSION:Serum ALR level is helpful in estimating the survival time of patients with HF, and ALR may play an important role in hepatocarcinogenesis.

    (Hepatobiliary Pancreat Dis Int 2010; 9: 492-498)

    liver regeneration; expression level; hepatic failure; hepatocellular carcinoma; chronic hepatitis B

    Introduction

    Human liver diseases such as chronic hepatitis, hepatic failure (HF), and hepatocellular carcinoma (HCC) are all accompanied by hepatocyte injury and regeneration.[1]Liver regeneration is a complicated process involving many agents, and augmenter of liver regeneration (ALR) is an important polypeptide in this process. Early experiments postulated the presence of a heat-stable hepatic stimulatory substance (HSS) in the liver, since extracts from weanling or hepatectomized rat livers result in augmentation of hepatocyte proliferation. Later, the peptide purified from HSS was renamed ALR. Unlike complete mitogens such as hepatocyte growth factor (HGF) or transforming growth factor (TGF-α), ALR was defined as a co-mitogen or "secondary" mitogen.[2]It was found to be constitutively expressed in hepatocytes in an inactive form, and released from the liver after activation during regeneration. Animal research revealed changes in the level of ALR in serum at the early stage of liver regeneration, earlier than other growth factors:[3]

    after 70% hepatectomy the level of ALR in the blood rises dramatically, peaking after 12 hours. Serum ALR level well reflects hepatocyte ALR expression level and the activation of liver regeneration. Recent experiments also showed an increase of ALR expression in human liver cirrhosis and carcinoma,[4]and the suppressedexpression of ALR subsequently inhibits the growth of HepG2 cells. Anti-hALR antibody was found to partially inhibit the autonomous growth of HepG2 cells.[5,6]All the above findings confirm the relationship between ALR and hepatocyte regeneration. The balance between hepatocyte injury and regeneration determines the turnover of many liver diseases.[7]In the present study, serum ALR levels and ALR mRNA expression levels were measured in different liver diseases to determine the relationship between ALR, hepatocyte regeneration, and liver disease, especially HF and HCC.

    Methods

    The study protocols and methods were approved by the Animal Care Ethics Committee and Clinical Investigation Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China).

    Preparation of natural human ALR (nhALR) and anti-nhALR antibody

    The recombinant expression vector of pET28a(+)/ hALR was constructed, and the recombinant human ALR (rhALR) protein of about 23 kDa was expressed and purified as reported previously.[8]To obtain nhALR, an Xa-arrest Kit (Novagen Germany) was used to excise the recombined peptide part of rhALR, and the Xa protease recognized as the continuous amino acids Ile-Glu-Gly-Arg. Thus we obtained a soluble nhALR protein of about 15 kDa. Amicon Ultra-4 (Millipore, USA) was used to desalt and concentrate the protein. The concentration of the nhALR protein was determined in a SmartSpecTMplus spectrophotometer (Bio-Rad, USA) by a Bradford protein assay kit and stored at -80 ℃ until use.

    We obtained murine polyclonal antibodies against nhALR from Balb/C mice. Twenty-four female mice (8 weeks old, weighing 19-22 g) were used for immunization and they were divided into an immune group and a control group, each of 12 mice. Briefly, approximately 40 mg of nhALR protein emulsified with an equal volume of Freund's complete adjuvant (Sigma, USA) was injected at multiple intradermal sites to the immune group (nhALR was diluted to 80 mg/ml, and 0.5 ml nhALR was mixed with 0.5 ml Freund's complete adjuvant); physiologic saline was injected into the control group for negative control. The same dose of protein or physiologic saline emulsified in Freund's incomplete adjuvant was injected 2 and 4 weeks after the first injection. After 7 days, blood was collected from the eyeballs and clotted by overnight incubation at room temperature, then centrifuged at 3000 g for 15 minutes. The serum was collected and the IgG fraction was purified before use as antibodies. A Montage antibody purification kit (Millipore, USA) was used to isolate the IgG fraction from the murine antiserum. The serum was diluted with binding buffer A and loaded on a PROSEP?-A spin column to collect the IgG fraction. IgG collected from the control group was used as control antibody.

    Identification of anti-nhALR antibody by Western blotting

    nhALR protein was separated on 15% SDS-PAGE and transferred onto a 0.2 μm pore polyvinylidene fluoride membrane (Millipore USA) at 220 mA for 2 hours in a Bio-Rad Transblot electrophoretic transfer cell for Western blotting analysis. The non-specific sites were blocked with 5% nonfat milk in TBS, the membrane was washed in TBS and incubated with anti-nhALR antibody (1 μg/ml) in blocking buffer, followed by washing and incubation with horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins (1∶1000, DakoCytomation, Denmark). The ALR-anti-ALR complex was treated with a mixture of 2× stable peroxide solution and 2× luminol/enhancer solution (Novagen, Germany), and chemoluminescence was recorded on Fuju X-ray film.

    To determine whether anti-nhALR antibody combines with ALR in hepatocytes, we extracted total proteins from HepG2 cells and immortalized human hepatocytes[9]with Mammalian Protein Extraction Reagent (Pierce, America) and separated the protein on 15% denatured or natured SDS-PAGE; further detection was performed as described above.

    Enzyme-linked immunosorbent assay (ELISA)

    Serial dilutions of nhALR protein were prepared: 10 and 1 μg/ml, 100, 50, 10, 5, 2, and 1 ng/ml, and 500, 250, 125, and 62.5 pg/ml. Well plates (96 wells) were coated with anti-nhALR antibody (0.1 μg/well) in 100 μl coated buffer overnight at 4 ℃ and incubated with blocking solution (PBS containing 5% nonfat milk) at 37 ℃ for 2 hours. After washing with PBS-T, serial dilutions of nhALR protein were incubated at 37 ℃ for 1.5 hours, then anti-nhALR antibody (0.1 μg/well in 100 μl blocking solution) was added. IgG collected from the control group was used for negative control. After 2 hours incubation at room temperature, plates were rinsed three times with PBS-T, and 100 μl of 1∶2000-diluted horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins (1∶1000, DakoCytomation Denmark) was added to each well for 1 hour incubation at room temperature. After washing five times, the enzyme activity was determined by adding 100 μl of 3, 3', 5,5'-tetramethyllbenzidine substrate solution. Optical density was read at dual absorbance of 450 nm and 630 nm with an ELISA plate reader (Bio-Rad) after incubating for 10 minutes.

    Determination of ALR level in human serum by ELISA

    Human serum was obtained from 72 patients classified into 4 groups (Table 1): 20 patients with HCC, of whom 6 accepted surgical resection; 18 with HF caused by hepatitis B virus, of whom 5 received orthotopic liver transplantation (OLT); 24 with chronic hepatitis B; and 10 healthy persons without liver disease. Of the 18 HF patients, 6 were improved through artificial liver support system (ALSS) therapy and rehabilitation and left hospital after 1-2 months, whereas the other 12 deteriorated in spite of ALSS therapy (7 died and 5 received OLT). When the patients met the diagnostic criteria of HF, their serum was collected on days 1, 2, and 3 before ALSS therapy. Blood samples collected from the 72 patients were stored at room temperature overnight and centrifuged at 3000 ×g for 10 minutes to isolate the serum. ELISA detection was performed as described above.

    HCC was diagnosed pathologically and HF was diagnosed according to the clinical symptoms, laboratory results, or pathological findings. Diagnostic workup included physical examination, laboratory tests, and liver pathology according to the criteria described inLiver Diseases of the Chinese Medical Associationin 2000.

    ALR mRNA expression in liver tissue

    HCC tissues were obtained from the 6 patients with HCC who accepted surgical resection; necrotic or inflamed liver tissues from the 5 patients with HF who received OLT; and control liver tissues were from healthy donors for OLT. The operations were performed at our hospital. Informed consent to utilize the liver tissues for mRNA extraction was given by the patients or their relatives. HCC and HF were diagnosed pathologically.

    Table 1. Patient characteristics

    Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)

    ALR and β-actin were synthesized in our laboratory, and their concentrations were determined by absorbance at 260 nm (SmartSpecTMplus Spectrophotometer, Bio-Rad). Ten-fold serial dilutions from 1×100 to 1×1010copies/μl were prepared.

    One hundred milligrams of each liver tissue sample was homogenized in a small earthenware basin with liquid nitrogen and total RNA was isolated using Trizol reagent as described by the manufacturer (Invitrogen. Grand Island, NY, USA). RNA concentration was determined by absorbance at 260 nm, transformed into cDNA, and stored at -80 ℃ until use.

    The level of β-actin mRNA was measured to determine the efficiency of cDNA synthesis and reverse transcription of different batches of mRNA. The PCR primers specific for ALR cDNA were 5'-TAA GGA TCC ATG CGG ACG CAG CAG AAG-3' (sense) and 5'-TAA CTC GAG CTA GTC ACA GGA GCC ATC-3' (antisense), and for β-actin cDNA 5'-GGC ATC CTC ACC CTG AAG TA-3' (sense) and 5'-TCG GGT GTT GAA GGT CTC AA-3' (antisense).

    Real-time PCR (20 μl) was performed using the SYBR Premix Ex TaqTMkit (Takara Biotechnology) in accordance with the manufacturer's protocol on an Option II real-time detection system (Bio-Rad Laboratories, Veenendaal, The Netherlands). Real-time RT-PCR data were analyzed by MJ Option MonitorTManalysis software version 3.1. The Ct value analysis, PCR efficiency, linearity, slopes of the standard curves, relative quantity of fluorescence, and dissociation curve analysis were calculated by the Strata gene software program built into the Option II apparatus.

    Immunohistochemical analysis

    The liver samples from HF and HCC patients were embedded in paraffin wax and 4-μm sections were cut. Standard pretreatment was done; anti-nhALR antibody diluted in 1∶100 in block solution was pipetted onto the sections and incubated overnight at 4 ℃, then the sections were washed three times with PBS and 1∶1000-diluted horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins were added and incubated at 37 ℃ for 1 hour. Staining was completed by diaminobenzidine (DAB) and counterstaining was with hematoxylin. The following negative controls were performed: 1) IgG collected from the Balb/C mice of the control group was used to replace the anti-nhALR antibody, and 2) anti-nhALR antibody was blocked with nhALR for 1 hour at 37 ℃ before addition.

    Statistical analysis

    Statistical analysis was performed using SPSS (version 13.0) for Windows. Student'sttest between two groups and LSDttest between several groups were used. APvalue less than 0.05 was considered statistically significant.

    Results

    rhALR and nhALR

    SDS-PAGE analysis showed the expected rhALR protein of about 23 kDa before the recombined peptide was excised, and the nhALR protein of about 15 kDa which was consistent with that reported previously (Fig. 1).

    Western blotting analysis

    Fig. 1. SDS-PAGE analysis of rhALR and nhALR. M: protein marker; lane 1: rhALR protein about 23 kDa; lane 2: nhALR protein about 15 kDa.

    Fig. 2. Western blotting analysis of nhALR and ALR in HepG2 cells/immortalized human hepatocytes. M: nhALR; lane 1: total protein extracted from immortalized human hepatocytes; lane 2: total protein extracted from HepG2 cells. A: Western blotting under denatured condition (100 mmol/L dithiothreitol, DTT); B: Western blotting under natural condition (without DTT).

    Anti-nhALR antibody immunoreacted with nhALR protein (Fig. 2). Anti-nhALR antibody-positive protein was present in the extracts prepared from both cell lines: immunoreactive protein strips of total protein extracted from HepG2 cells and immortalized human hepatocytes was about 23 kDa (denatured condition) and more than 40 kDa (dimeric structure under natural conditions) as reported previously. Thus the anti-nhALR antibody was specifically combined with ALR in HepG2 cells and ALR in human serum (Fig. 2).

    Table 2. Serum dual absorbance at 450 and 630 nm and serum ALR levels of 72 patients

    Fig. 3. Relationship between nhALR concentration and dual absorbance at 450 and 630 nm.

    Table 3. Absolute ALR and β-actin mRNA levels of 11 patients and 2 controls

    ELISA analysis

    There was a close relationship between nhALR concentration dual absorbance at 450 and 630 nm. Besides a satisfactory linear relationship from 62.5 pg/ml to 2 ng/ml was found (Fig. 3), as a good reference to analysis of the ALR concentration in patient serum.

    Determination of serum ALR levels

    The serum ALR levels of the 72 patients (Table 2) were determined by ELISA. ALR levels were calculated by dual absorbance at 450 and 630 nm according to the linear relationship (Fig. 3). ALR levels were higher in the 6 improved patients (1613.5±369.6 pmol/ml) than in the 12 deteriorating patients (462.3±235.8 pmol/ml) or the other 54 patients and healthy persons (P<0.05). ALR levels in the 12 deteriorating patients were lower than those of the other 54 patients and healthy persons (P<0.05). ALR levels were similar, in the HCC patients (917.9±332.7 pmol/ml) and chronic hepatitis B patients (969.2±332.6 pmol/ml) and higher than in the healthy persons (806.9±240.8 pmol/ml) but these findings were not statistically different (P>0.05).

    Real-time RT-PCR analysis

    The absolute ALR and β-actin mRNA levels of the 11 patients and 2 controls are listed in Table 3. The ALR expression after normalization to β-actin was much higher in HCC liver tissues [10E6.24 (1.74×106) copies/μl] than in HF receiving OLT [10E3.45 (2.82×103) copies/μl] or healthy persons [10E4.31 (2.04×104) copies/μl].

    Fig. 4. ALR protein expression in paraffin-embedded HCC and HF human liver tissue. A, B: Fields from HCC liver showing positive immunostaining of the majority of hepatocytes in cytoplasm but negative in nucleus, and rare in cholangiocytes and endothelial cells. C: Field from HF liver showing bile thrombus and less positive immunostaining than that in HCC liver sections. D, E: Negative controls (see Methods) showing lack of any positive immunostaining in hepatocytes, cholangiocytes, and endothelial cells.

    Immunohistochemical analysis

    Immunostaining was positive in the hepatocyte cytoplasm but negative in the nucleus, and rare in cholangiocytes and endothelial cells. Positive immunostaining was more intense in HCC liver tissue than in HF liver tissue. No positive immunostaining was found in negative controls (Fig. 4).

    Discussion

    ALR is a recently discovered hepatotrophic protein and unique cytokine which specifically stimulates cells of hepatic origin to grow regardless of genus.[10,11]ALR is absent from the serum of normal adult animals,[12]but a recent study[3]found that ALR is synthesized constantly in hepatocytes in an inactive form and is detected in normal adult mouse serum. Animal research found that the concentration of this factor in serum rises dramatically after 70% hepatectomy.[3]In our study, ALR was also detected in human serum, and the ALR levels in human liver diseases were significantly different. The fact that ALR is synthesized constantly and is activated during liver regeneration shows its importance in liver function and regeneration.

    The liver has extraordinary regenerative power, and adequate regeneration usually occurs in patients with acute and chronic liver diseases, although hepatocyte necrosis is extensive. However, in some lethal or acute fulminant HF, the number of regenerative hepatocytesis clearly fewer than in surviving patients, and it appears that regeneration failure causes death in such patients.[13]In our study, different serum ALR levels were found in different HF patients, and they foreshowed completely different prognoses: patients with higher serum ALR levels had liver function improved enough through ALSS therapy and rehabilitation to leave hospital; conversely, patients with lower ALR levels deteriorated to the point of death or had to receive OLT. Decreased serum ALR levels may identify patients at risk of lethal liver failure and represent the trigger for maintaining intensive medical treatment or turning to salvage liver transplantation. High serum ALR levels represent a high level of hepatocyte regeneration. The survival rates of patients with different ALR levels were statistically significant, suggesting that ALR level is helpful in estimating the survival time of patients with HF.

    HGF is another important polypeptide in the process of liver regeneration. A study found that the serum HGF level in HF patients is high,[14]and increasing HGF levels in HF patients result in deterioration, which seems opposite to our result. But we also found in surviving patients that the HGF was high at first and then decreased, while in the patients who got worse and died, the serum HGF level increased continuously. In our study, we only measured the early level of serum ALR (days 1, 2, and 3 before ALSS therapy), because all HF patients accepted ALSS therapy, and after this therapy the serum ALR level cannot reflect its real level. We found the early ALR level correlated with the prothrombin time and the prognosis. Unlike HGF, ALR is synthetized by hepatocytes, the early serum ALR level reflects the degree of regeneration of hepatocytes, and the regeneration level determines survival or death. ALR as a hepatotrophic factor takes a core place in the process of liver regeneration and may promote it by reducing liver-resident natural killer cell activity in human liver diseases.[15,16]

    HCC is now the fifth most frequent malignant tumor in the world (564 000 cases annually) and the third cause for cancer death.[17,18]There is a growing understanding of the molecular mechanisms inducing hepatocarcinogenesis, which almost never occurs in healthy liver, but the cancer risk increases sharply in response to chronic liver injury at the cirrhosis stage.[19]A detailed understanding of epidemiologic factors and molecular mechanisms associated with HCC could ultimately improve our current concepts for screening and treatment of this disease.[20]

    In our study, similar serum ALR levels were noted in HCC patients and chronic hepatitis B patients, and no significant difference was found between these patients and healthy persons. But the ALR mRNA expression levels in HCC liver tissues were higher than those in the liver tissue of healthy persons. All the above showed that ALR was expressed highly in HCC hepatocytes compared with healthy persons, but the serum ALR level in HCC patients was not high. The reason for the disparity between mRNA expression level and serum level of ALR in HCC is not yet understood. Immunohistochemical data showed that ALR existed predominantly in hepatocyte cytoplasm and positive immunostaining was more intense in HCC than in HF (which led to death). Recent research revealed that ALR stimulates the proliferation of HepG2 and QGY cells dose-dependentlyin vitro, but has no influence on the proliferation of primary rat hepatocytes. The expression of ALR is much higher in HCC liver tissues than in normal liver tissues, and it is not related to the differentiation and size of the carcinoma.[21]Another study also found that hALR is highly expressed by HepG2 cells and maintains the autonomous growth of hepatoma cellsin vitrothrough an autocrine mechanism, and anti-hALR antibody partly inhibits the autonomous growth of HepG2 cellsin vitro. The short interfering RNA targeting hALR gene specifically suppresses the expression of hALR, and subsequently inhibits the growth of HepG2 cells.[5,6]ALR might play an important role in the occurrence and development of HCC. The findings suggest an important role for ALR in hepatocarcinogenesis and therefore its potential value in clinical diagnosis and therapy of HCC.

    Because of the core place of ALR in liver function and regeneration, and its close relationship with human liver diseases such as HF and HCC, there is an increasing necessity to extend research on mammalian ALR protein in different patients with different kinds of liver diseases or at different stages of hepatitis.

    Funding:This work was supported by grants from the National Natural Science Foundation of China (30972592 and 30970747), and Zhejiang Provincial Natural Science Foundation (Y2090010).Ethical approval:Not needed.

    Contributors:SJF and LJ proposed the study. YHY wrote the first draft. XDR analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. SJF is the guarantor.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Pawlowski R, Jura J. ALR and liver regeneration. Mol Cell Biochem 2006;288:159-169.

    2 de Juan C, Benito M, Alvarez A, Fabregat I. Differential proliferative response of cultured fetal and regenerating hepatocytes to growth factors and hormones. Exp Cell Res 1992;202:495-500.

    3 Gandhi CR, Kuddus R, Subbotin VM, Prelich J, Murase N, Rao AS, et al. A fresh look at augmenter of liver regeneration in rats. Hepatology 1999;29:1435-1445.

    4 Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005;47:57-66.

    5 Tang L, Sun H, Zhang L, Guo H, Zhang L, Liu Q. Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2. Ai Zheng 2006;25:671-676.

    6 Tang L, Sun H, Zhang L, Guo H, Chen XH, Deng JC, et al. Effects of anti-human augmenter of liver regeneration monoclonal antibody on proliferation of HepG2 cellsin vitro. J Chongqing Med Univ 2005;30:7-9, 17.

    7 Elias E. Liver failure and liver disease. Hepatology 2006;43: S239-242.

    8 Sheng J, Yu H, Li J, Sheng G, Zhou L, Lu Y. Cloning and expression of the human augmenter of liver regeneration at low temperature in Escherichia coli. J Biochem Biophys Methods 2007;70:465-470.

    9 Li J, Li LJ, Cao HC, Sheng GP, Yu HY, Xu W, et al. Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy. ASAIO J 2005;51:262-268.

    10 LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975;248:273-284.

    11 Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994;91:8142-8146.

    12 Giorda R, Hagiya M, Seki T, Shimonishi M, Sakai H, Michaelson J, et al. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996;2:97-108.

    13 Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003;23:203-215.

    14 Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992;15:5-11.

    15 Vujanovic NL, Polimeno L, Azzarone A, Francavilla A, Chambers WH, Starzl TE, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995;154: 6324-6238.

    16 Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol 2000;35:112-119.

    17 Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35: 519-524.

    18 Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, et al. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation 2007;75:843-852.

    19 Fausto N, Webber EM. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis. Prog Liver Dis 1993;11:115-137.

    20 El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576.

    21 Sun H, Yu HF, Wu CX, Guan XQ, Liu Q. Expression of augmenter of liver regeneration in hepatic tumor cells and its clinical significance. Zhonghua Gan Zang Bing Za Zhi 2005; 13:205-208.

    January 15, 2010

    Accepted after revision April 27, 2010

    Author Affiliations: State Key Laboratory of Infectious Disease and Department of Infectious Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Yu HY, Xiang DR, Huang HJ, Li J and Sheng JF)

    Ji-Fang Sheng, MD, PhD, Department of Infectious Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Tel: 86-571-87236759; Fax: 86-571-87236755; Email: sania8@163.com)

    ? 2010, Hepatobiliary Pancreat Dis Int. All rights reserved.

    久久国产精品人妻蜜桃| 欧美精品亚洲一区二区| 99国产极品粉嫩在线观看| 热99久久久久精品小说推荐| 男女下面插进去视频免费观看| 欧美人与性动交α欧美精品济南到| 熟女少妇亚洲综合色aaa.| 久久人人爽av亚洲精品天堂| 国产无遮挡羞羞视频在线观看| 热99久久久久精品小说推荐| 18在线观看网站| av网站在线播放免费| 女人爽到高潮嗷嗷叫在线视频| 中文字幕制服av| 在线精品无人区一区二区三| 亚洲美女黄色视频免费看| 国产片内射在线| 欧美激情久久久久久爽电影 | 美女高潮到喷水免费观看| 这个男人来自地球电影免费观看| av又黄又爽大尺度在线免费看| 久久国产精品人妻蜜桃| 一边摸一边做爽爽视频免费| 他把我摸到了高潮在线观看 | 欧美中文综合在线视频| 久热爱精品视频在线9| 亚洲第一av免费看| 亚洲av欧美aⅴ国产| 国产男人的电影天堂91| 国产男女内射视频| 国产伦理片在线播放av一区| 久久九九热精品免费| 丰满人妻熟妇乱又伦精品不卡| 国产老妇伦熟女老妇高清| 91成人精品电影| 国产成人精品在线电影| 日韩制服骚丝袜av| 国产在视频线精品| 欧美97在线视频| 精品免费久久久久久久清纯 | 青草久久国产| 一级毛片女人18水好多| 中文字幕制服av| 黄色视频不卡| 日韩制服骚丝袜av| 在线十欧美十亚洲十日本专区| videos熟女内射| 国产成人精品在线电影| 少妇的丰满在线观看| 美国免费a级毛片| 日本五十路高清| 亚洲人成77777在线视频| 操出白浆在线播放| 天天躁日日躁夜夜躁夜夜| 久久精品国产a三级三级三级| 久久久国产精品麻豆| 美女主播在线视频| 99久久99久久久精品蜜桃| 丝瓜视频免费看黄片| 女人久久www免费人成看片| 亚洲人成电影免费在线| 大片免费播放器 马上看| 97人妻天天添夜夜摸| 每晚都被弄得嗷嗷叫到高潮| 日韩精品免费视频一区二区三区| 午夜影院在线不卡| 久久精品国产a三级三级三级| 中文字幕制服av| 亚洲欧美色中文字幕在线| av天堂在线播放| 国产精品国产av在线观看| 国产福利在线免费观看视频| 男女高潮啪啪啪动态图| 十八禁网站网址无遮挡| 亚洲欧美精品自产自拍| 久久久精品94久久精品| 亚洲欧美日韩另类电影网站| 精品人妻熟女毛片av久久网站| 18在线观看网站| 精品第一国产精品| www.自偷自拍.com| 国产精品九九99| 亚洲人成电影免费在线| 亚洲国产欧美网| 涩涩av久久男人的天堂| 欧美在线一区亚洲| 久久久久久久久免费视频了| 三上悠亚av全集在线观看| 99re6热这里在线精品视频| 成年人黄色毛片网站| xxxhd国产人妻xxx| 精品亚洲乱码少妇综合久久| 69av精品久久久久久 | 久久精品亚洲熟妇少妇任你| 91麻豆精品激情在线观看国产 | 丝袜喷水一区| 一级片免费观看大全| 亚洲精品国产一区二区精华液| 在线十欧美十亚洲十日本专区| avwww免费| 中国美女看黄片| 国产人伦9x9x在线观看| 建设人人有责人人尽责人人享有的| 欧美黑人欧美精品刺激| 99热网站在线观看| 97人妻天天添夜夜摸| 18禁国产床啪视频网站| 国产熟女午夜一区二区三区| 无限看片的www在线观看| 嫩草影视91久久| 国产精品av久久久久免费| 欧美黄色淫秽网站| 黑人巨大精品欧美一区二区mp4| 亚洲av美国av| 一进一出抽搐动态| 曰老女人黄片| 捣出白浆h1v1| 精品欧美一区二区三区在线| 亚洲欧美激情在线| 视频区欧美日本亚洲| 少妇的丰满在线观看| 九色亚洲精品在线播放| 五月开心婷婷网| 日韩制服骚丝袜av| 国产精品久久久久成人av| 欧美在线黄色| 久久九九热精品免费| 男男h啪啪无遮挡| 精品亚洲成国产av| 最新的欧美精品一区二区| 天堂8中文在线网| 老熟妇仑乱视频hdxx| 90打野战视频偷拍视频| 伦理电影免费视频| 99国产极品粉嫩在线观看| 日本a在线网址| 欧美另类一区| 午夜免费成人在线视频| 亚洲精品日韩在线中文字幕| 久久精品国产综合久久久| 在线观看一区二区三区激情| 一区二区三区精品91| 亚洲色图综合在线观看| 欧美黑人精品巨大| 欧美成狂野欧美在线观看| 99久久99久久久精品蜜桃| 日韩欧美一区视频在线观看| 欧美日韩亚洲高清精品| 91成年电影在线观看| 十分钟在线观看高清视频www| 超碰成人久久| 亚洲成av片中文字幕在线观看| 中文字幕人妻熟女乱码| 成人国产一区最新在线观看| 国产福利在线免费观看视频| 国产成人免费无遮挡视频| 亚洲av成人不卡在线观看播放网 | 国产精品久久久久成人av| 久久久精品免费免费高清| 久久香蕉激情| 色老头精品视频在线观看| 久久中文看片网| 人人妻人人澡人人看| 我要看黄色一级片免费的| 在线永久观看黄色视频| 亚洲国产av影院在线观看| 手机成人av网站| 久久av网站| 亚洲欧美成人综合另类久久久| 一本综合久久免费| 在线精品无人区一区二区三| 国产成人免费观看mmmm| 一级a爱视频在线免费观看| 十八禁网站网址无遮挡| 国产亚洲午夜精品一区二区久久| 在线亚洲精品国产二区图片欧美| 亚洲国产欧美一区二区综合| 脱女人内裤的视频| 精品亚洲成国产av| 亚洲一卡2卡3卡4卡5卡精品中文| 手机成人av网站| 老汉色av国产亚洲站长工具| 亚洲欧洲日产国产| 97在线人人人人妻| 免费观看a级毛片全部| 午夜福利影视在线免费观看| 久久久久精品人妻al黑| 日本猛色少妇xxxxx猛交久久| 久久久精品区二区三区| 久久中文字幕一级| 亚洲欧美日韩高清在线视频 | 国产亚洲精品久久久久5区| 国产人伦9x9x在线观看| 亚洲第一av免费看| 国产精品秋霞免费鲁丝片| 久久人人爽av亚洲精品天堂| 91成人精品电影| 国产成人影院久久av| 亚洲成人手机| 18禁国产床啪视频网站| 亚洲国产欧美在线一区| 韩国精品一区二区三区| 欧美成狂野欧美在线观看| 一本大道久久a久久精品| 久久精品国产亚洲av香蕉五月 | 欧美日韩国产mv在线观看视频| 久久久久网色| 乱人伦中国视频| 久久久水蜜桃国产精品网| 男女下面插进去视频免费观看| 91麻豆av在线| 一本大道久久a久久精品| 自线自在国产av| 久久精品国产亚洲av香蕉五月 | 免费在线观看影片大全网站| 久久毛片免费看一区二区三区| 免费观看人在逋| 国产成人av教育| 看免费av毛片| 妹子高潮喷水视频| 国产又色又爽无遮挡免| 亚洲av日韩在线播放| 狂野欧美激情性xxxx| 一本大道久久a久久精品| 亚洲第一av免费看| 国产伦人伦偷精品视频| 精品久久蜜臀av无| 成年av动漫网址| 天天操日日干夜夜撸| 国产99久久九九免费精品| 日韩电影二区| 性少妇av在线| 久久久久久免费高清国产稀缺| 国产伦人伦偷精品视频| 亚洲情色 制服丝袜| 在线观看人妻少妇| 亚洲天堂av无毛| 久久青草综合色| 大码成人一级视频| 一本综合久久免费| 午夜福利视频在线观看免费| 女性生殖器流出的白浆| 美女主播在线视频| 高潮久久久久久久久久久不卡| 国产亚洲av高清不卡| 日韩视频在线欧美| 免费女性裸体啪啪无遮挡网站| 国产一区二区三区av在线| 久久午夜综合久久蜜桃| 国产精品一区二区精品视频观看| 精品亚洲成a人片在线观看| 成人免费观看视频高清| av福利片在线| av国产精品久久久久影院| 少妇 在线观看| 久久狼人影院| 欧美日韩亚洲综合一区二区三区_| 久9热在线精品视频| 淫妇啪啪啪对白视频 | 18禁国产床啪视频网站| 国产精品成人在线| av不卡在线播放| 日本黄色日本黄色录像| 亚洲精品国产色婷婷电影| 老熟女久久久| 制服诱惑二区| av免费在线观看网站| 老司机影院毛片| 高潮久久久久久久久久久不卡| 成年动漫av网址| 老司机午夜十八禁免费视频| 国产一级毛片在线| 色精品久久人妻99蜜桃| 丝袜脚勾引网站| 免费高清在线观看日韩| 国产1区2区3区精品| 亚洲成人国产一区在线观看| 日本猛色少妇xxxxx猛交久久| 国产在线一区二区三区精| 香蕉国产在线看| 一二三四在线观看免费中文在| 天天添夜夜摸| 日日爽夜夜爽网站| 亚洲精品美女久久久久99蜜臀| 18禁裸乳无遮挡动漫免费视频| 在线亚洲精品国产二区图片欧美| 精品久久久久久久毛片微露脸 | 午夜免费成人在线视频| 女警被强在线播放| 久热爱精品视频在线9| 日韩欧美免费精品| netflix在线观看网站| 免费在线观看完整版高清| 亚洲国产欧美在线一区| 在线观看一区二区三区激情| 两性夫妻黄色片| 欧美精品亚洲一区二区| 交换朋友夫妻互换小说| 女人爽到高潮嗷嗷叫在线视频| 啦啦啦 在线观看视频| 国产精品一区二区在线不卡| 午夜福利乱码中文字幕| 狂野欧美激情性xxxx| 国产深夜福利视频在线观看| 99精品久久久久人妻精品| 天堂俺去俺来也www色官网| 美女大奶头黄色视频| 午夜福利影视在线免费观看| 国产一区二区三区综合在线观看| 成人影院久久| 成年动漫av网址| 狂野欧美激情性xxxx| 乱人伦中国视频| 国产av又大| 久久久久国产精品人妻一区二区| 久久免费观看电影| 日韩 亚洲 欧美在线| 国产成人精品无人区| 日韩免费高清中文字幕av| 欧美激情极品国产一区二区三区| 国产日韩一区二区三区精品不卡| 十八禁高潮呻吟视频| 一级,二级,三级黄色视频| 9色porny在线观看| 欧美亚洲日本最大视频资源| 亚洲久久久国产精品| 一区在线观看完整版| 天天躁日日躁夜夜躁夜夜| 亚洲欧美色中文字幕在线| 99香蕉大伊视频| 午夜两性在线视频| 亚洲精品日韩在线中文字幕| 欧美精品亚洲一区二区| 电影成人av| 久久久久网色| 精品福利永久在线观看| 岛国在线观看网站| 在线看a的网站| 无限看片的www在线观看| 91成年电影在线观看| 黄色毛片三级朝国网站| videosex国产| 亚洲中文日韩欧美视频| 国产精品.久久久| 精品国内亚洲2022精品成人 | 日韩一区二区三区影片| 桃红色精品国产亚洲av| 在线观看www视频免费| av超薄肉色丝袜交足视频| 免费在线观看视频国产中文字幕亚洲 | 亚洲黑人精品在线| 夜夜骑夜夜射夜夜干| 99国产综合亚洲精品| 王馨瑶露胸无遮挡在线观看| 国产av精品麻豆| 91九色精品人成在线观看| 精品久久久久久久毛片微露脸 | 国产一卡二卡三卡精品| 多毛熟女@视频| 男人添女人高潮全过程视频| 亚洲欧洲日产国产| 亚洲欧美色中文字幕在线| 99国产精品一区二区蜜桃av| 欧美一级a爱片免费观看看 | 俺也久久电影网| 可以在线观看毛片的网站| 又粗又爽又猛毛片免费看| 我要搜黄色片| 91老司机精品| 久久久久久久久久黄片| 黄色a级毛片大全视频| 久久精品国产清高在天天线| 淫妇啪啪啪对白视频| 99精品欧美一区二区三区四区| 中文字幕最新亚洲高清| 国产私拍福利视频在线观看| 国产成人av激情在线播放| 国产精品一区二区三区四区久久| 窝窝影院91人妻| 亚洲av成人av| 看免费av毛片| 女生性感内裤真人,穿戴方法视频| 国产激情欧美一区二区| 一二三四社区在线视频社区8| 一级毛片女人18水好多| 国产三级黄色录像| 丁香六月欧美| 亚洲狠狠婷婷综合久久图片| 国产熟女xx| 日韩欧美免费精品| 曰老女人黄片| 亚洲精品久久国产高清桃花| 精品国产亚洲在线| 麻豆国产av国片精品| 午夜福利高清视频| 欧美色欧美亚洲另类二区| 午夜免费成人在线视频| 国产69精品久久久久777片 | 亚洲欧美一区二区三区黑人| 国产精品国产高清国产av| 最近最新中文字幕大全免费视频| 777久久人妻少妇嫩草av网站| 亚洲五月天丁香| 婷婷精品国产亚洲av| 色精品久久人妻99蜜桃| 日韩中文字幕欧美一区二区| 1024手机看黄色片| 国产高清视频在线播放一区| 久99久视频精品免费| 波多野结衣高清无吗| 99久久精品国产亚洲精品| 亚洲一区二区三区色噜噜| 最近最新免费中文字幕在线| 久久这里只有精品19| 国内久久婷婷六月综合欲色啪| 午夜免费成人在线视频| 午夜免费激情av| 在线十欧美十亚洲十日本专区| 免费高清视频大片| 国产又黄又爽又无遮挡在线| 午夜免费成人在线视频| 久久久久国内视频| 手机成人av网站| 成人午夜高清在线视频| 人人妻人人看人人澡| 国产欧美日韩一区二区三| 成人18禁高潮啪啪吃奶动态图| 美女午夜性视频免费| e午夜精品久久久久久久| 国产视频一区二区在线看| av在线天堂中文字幕| 中文字幕高清在线视频| 51午夜福利影视在线观看| 欧美激情久久久久久爽电影| 桃红色精品国产亚洲av| 亚洲专区中文字幕在线| 99久久综合精品五月天人人| 香蕉av资源在线| 久久久久久久久免费视频了| 国产精品日韩av在线免费观看| 91九色精品人成在线观看| а√天堂www在线а√下载| av免费在线观看网站| 黄片大片在线免费观看| 欧美一区二区精品小视频在线| 久久久久性生活片| 一区福利在线观看| 国产aⅴ精品一区二区三区波| 美女高潮喷水抽搐中文字幕| 一级毛片高清免费大全| 搡老妇女老女人老熟妇| 在线观看免费视频日本深夜| 久久香蕉激情| 无遮挡黄片免费观看| 国产激情久久老熟女| 亚洲av美国av| 久久 成人 亚洲| 国产一区二区三区在线臀色熟女| 三级毛片av免费| 日韩精品青青久久久久久| 欧美中文日本在线观看视频| 国产蜜桃级精品一区二区三区| 两个人看的免费小视频| 舔av片在线| 欧美激情久久久久久爽电影| 青草久久国产| 最好的美女福利视频网| 日本在线视频免费播放| 免费高清视频大片| 熟妇人妻久久中文字幕3abv| 又大又爽又粗| 成人国产一区最新在线观看| 精品久久蜜臀av无| 亚洲,欧美精品.| 91老司机精品| 视频区欧美日本亚洲| 亚洲最大成人中文| 成人手机av| 人人妻,人人澡人人爽秒播| 午夜福利成人在线免费观看| 91麻豆精品激情在线观看国产| 黄色毛片三级朝国网站| 岛国在线免费视频观看| 国产午夜福利久久久久久| 午夜激情福利司机影院| 一区福利在线观看| 啦啦啦观看免费观看视频高清| 亚洲九九香蕉| 国产亚洲av高清不卡| 黄色片一级片一级黄色片| 一级a爱片免费观看的视频| 久久午夜综合久久蜜桃| 中文字幕熟女人妻在线| 亚洲欧美精品综合一区二区三区| 久久久久九九精品影院| 此物有八面人人有两片| 日本三级黄在线观看| 亚洲精品美女久久av网站| 91九色精品人成在线观看| 男女视频在线观看网站免费 | 一边摸一边抽搐一进一小说| 97碰自拍视频| 午夜成年电影在线免费观看| 黄色视频不卡| 少妇熟女aⅴ在线视频| 日韩高清综合在线| 99国产极品粉嫩在线观看| 日本三级黄在线观看| 精品国产美女av久久久久小说| 午夜成年电影在线免费观看| 国内揄拍国产精品人妻在线| 日韩欧美在线二视频| 欧美黑人精品巨大| 亚洲avbb在线观看| 精品久久久久久,| 欧美黄色淫秽网站| 亚洲乱码一区二区免费版| 国产区一区二久久| 日本五十路高清| 很黄的视频免费| 久久久久亚洲av毛片大全| 狂野欧美白嫩少妇大欣赏| 久久久久久人人人人人| 一级作爱视频免费观看| 久久久久久人人人人人| 欧美日韩福利视频一区二区| 老汉色∧v一级毛片| 久久久国产成人免费| 久久久久久人人人人人| 免费在线观看黄色视频的| 好男人电影高清在线观看| bbb黄色大片| 国产三级中文精品| e午夜精品久久久久久久| 国产野战对白在线观看| 亚洲成a人片在线一区二区| 亚洲成人精品中文字幕电影| 久久精品国产99精品国产亚洲性色| 成人三级黄色视频| 99热这里只有精品一区 | 又紧又爽又黄一区二区| 国产欧美日韩一区二区精品| 国产一区二区在线观看日韩 | 欧美色视频一区免费| 欧美在线黄色| 成人欧美大片| 亚洲五月天丁香| 97碰自拍视频| 级片在线观看| 叶爱在线成人免费视频播放| 夜夜看夜夜爽夜夜摸| 夜夜夜夜夜久久久久| 亚洲,欧美精品.| 欧美乱色亚洲激情| 久9热在线精品视频| www日本黄色视频网| 男人的好看免费观看在线视频 | 国产成人精品久久二区二区91| 欧美性长视频在线观看| 亚洲国产精品成人综合色| 777久久人妻少妇嫩草av网站| 啪啪无遮挡十八禁网站| 精品少妇一区二区三区视频日本电影| 一级片免费观看大全| 日韩精品中文字幕看吧| 人成视频在线观看免费观看| 亚洲色图av天堂| 啪啪无遮挡十八禁网站| 国产精品免费视频内射| 男插女下体视频免费在线播放| 免费在线观看影片大全网站| 午夜老司机福利片| 国产亚洲精品第一综合不卡| 欧美成人免费av一区二区三区| 国产不卡一卡二| 级片在线观看| 国产av不卡久久| 99久久99久久久精品蜜桃| 一夜夜www| 日本成人三级电影网站| tocl精华| 久久欧美精品欧美久久欧美| 可以免费在线观看a视频的电影网站| 日韩精品免费视频一区二区三区| 最近最新中文字幕大全电影3| 九色成人免费人妻av| 在线观看舔阴道视频| 国产成人精品无人区| 在线a可以看的网站| 久久午夜亚洲精品久久| 嫩草影视91久久| 中出人妻视频一区二区| 国产精品久久久人人做人人爽| 九色国产91popny在线| 国产黄a三级三级三级人| 国产熟女xx| av超薄肉色丝袜交足视频| 老司机靠b影院| 欧美3d第一页| 国产精品久久久人人做人人爽| 一级毛片女人18水好多| 久久天躁狠狠躁夜夜2o2o| 最好的美女福利视频网| 99热这里只有是精品50| 母亲3免费完整高清在线观看| av中文乱码字幕在线| 欧美最黄视频在线播放免费| 精品久久久久久久末码| 久久久国产欧美日韩av| 亚洲精品av麻豆狂野| 这个男人来自地球电影免费观看| 97人妻精品一区二区三区麻豆| 黄色毛片三级朝国网站| 久久久久九九精品影院| 国产精品香港三级国产av潘金莲|